Acelrx pharmaceuticals announces abstract acceptance for podium presentation at plastic surgery: the meeting 2022

Hayward, calif. , aug. 11, 2022 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that an abstract, entitled, "experience in complex outpatient plastic surgery procedures using sufentanil sublingual tablets" has been accepted for podium presentation at plastic surgery: the meeting 2022, taking place october 27-30, 2022 in boston, ma.
ACRX Ratings Summary
ACRX Quant Ranking